Unusual stage-specific embryonic antigen (TEC-4) defined by a monoclonal antibody to embryonal carcinoma cells defective in the expression of embryoglycan

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid02574458

Most developmentally regulated epitopes identified on embryonal carcinoma cells and murine preimplantation embryos are associated with a glycoprotein-bound large glycan called embryoglycan. To prepare monoclonal antibodies recognizing other, less immunogenic stage-specific embryonic epitopes, we used embryoglycan-negative embryonal carcinoma cells P19XT.1.1 as immunogen. One monoclonal antibody prepared by this strategy was found to react specifically with mouse embryonal carcinoma and embryo-derived stem cell lines. The target epitope, TEC-4, was found to be expressed on eggs and two-cell embryos but was undetectable on later stages of mouse embryos and adult mouse tissues. NaDodSO4/PAGE of immunoaffinity-isolated antigen revealed that TEC-4 epitope is associated with glycoproteins of apparent Mr 120,000 and 240,000. The epitope was resistant to oxidation by sodium periodate and to digestion by endoglycosidase F but was sensitive to treatment with protein-denaturing agents and proteases, which suggested that the epitope is located in the protein moiety of the molecule. In the course of retinoic acid-induced differentiation of embryonal carcinoma cells the epitope disappeared before the onset of morphological differentiation. The combined data indicate that TEC-4 is an unusual stage-specific embryonic antigen that may be amenable to direct genetic analysis.

Zobrazit více v PubMed

Dev Biol. 1982 Feb;89(2):503-8 PubMed

Science. 1988 May 13;240(4854):889-95 PubMed

Exp Cell Res. 1989 Feb;180(2):326-40 PubMed

Mol Immunol. 1989 Feb;26(2):153-61 PubMed

Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PubMed

Nature. 1970 Aug 15;227(5259):680-5 PubMed

Proc Natl Acad Sci U S A. 1973 Nov;70(11):3170-4 PubMed

Immunol Rev. 1977 Jan;33:3-32 PubMed

Nature. 1977 Apr 7;266(5602):550-2 PubMed

Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565-9 PubMed

Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PubMed

Biochem J. 1980 Apr 1;187(1):1-20 PubMed

J Immunogenet. 1980 Dec;7(6):455-74 PubMed

J Immunol Methods. 1981;43(2):175-9 PubMed

Proc Natl Acad Sci U S A. 1981 Dec;78(12):7634-8 PubMed

Int J Cancer. 1982 May 15;29(5):523-31 PubMed

J Cell Biol. 1982 Aug;94(2):253-62 PubMed

Cell. 1982 Oct;30(3):697-705 PubMed

Mol Cell Biol. 1983 Dec;3(12):2271-9 PubMed

Dev Biol. 1984 Jan;101(1):225-8 PubMed

Lab Invest. 1984 Feb;50(2):147-62 PubMed

J Biochem. 1985 Jan;97(1):307-15 PubMed

Cell Differ. 1984 Dec;15(2-4):109-13 PubMed

Cell Differ. 1985 May;16(3):169-73 PubMed

Differentiation. 1986;31(3):174-82 PubMed

Proc Natl Acad Sci U S A. 1987 Aug;84(16):5798-802 PubMed

Cell Differ. 1987 Jul;21(2):119-30 PubMed

Immunogenetics. 1987;26(4-5):273-81 PubMed

J Cell Biochem. 1988 Jan;36(1):1-14 PubMed

Biochim Biophys Acta. 1988 Mar 11;968(3):291-9 PubMed

Differentiation. 1988 May;37(3):205-14 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...